Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Please note: We are reviewing Western blot images included in the antibody testing data in our catalog, including those provided by third parties. Unless expressly labeled or annotated as “raw-unedited”, Western blot images included in the antibody testing data in our catalog may have been edited, optimized or otherwise adjusted for presentation.
Quinoxyfen is a fungicide that has been identified as a priority hazardous substance due to its toxicity to aquatic organisms, as per the European Water Framework Directive. Its gene expression impacts include alterations in cyp19a1b, shank3a, gad1b, nrxn1a, and c-fos in zebrafish larvae, indicating potential environmental and biological risks. Structurally, quinoxyfen is synthesized into photometabolites like 2-chloro-10-fluorochromeno[2,3,4-de]quinoline, which is scalable for laboratory synthesis. Functionally, it poses significant risks to aquatic environments, leading to its ban in commercial products since 2019. Analytical methods for its detection are limited, with recent developments focusing on immunochemical analysis. The compound's synthesis and degradation pathways are crucial for understanding its environmental impact and regulatory status.
仅用于科研。不用于诊断过程。未经明确授权不得转售。